increased number of Howell-Jolly bodies_Tg(H2-K<b>-Jak2*V617F)2Shmd/0

http://metadb.riken.jp/0010178IC57BL6DBA2TgH2KbJak2V617F2Shmd0TgH2KbJak2V617F2Shmd

increased number of Howell-Jolly bodies_Tg(H2-K<b>-Jak2*V617F)2Shmd/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 2, Kazuya Shimoda
  http://metadb.riken.jp/db/mgi_rdf/MGI:5444026

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(H2-K<b>-Jak2*V617F)2Shmd/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(H2-K<b>-Jak2*V617F)2Shmd

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * DBA/2

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased number of Howell-Jolly bodies
  http://purl.obolibrary.org/obo/MP_0010178

文献

http://purl.org/net/cito/citesAsAuthority

• K. Shide, et.al., Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F., Leukemia, 2008, 22
  http://rdf.ncbi.nlm.nih.gov/pubmed/18033315